Related Experiment Videos
Natural killer cell lymphoma in the duodenum
Masahiko Sumi1, Tetsuzo Tauchi, Goro Sashida
1First Department of Internal Medicine, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan. m-sumi@mta.biglobe.ne.jp
Leukemia & Lymphoma
|April 15, 2003
Summary
This case study details a rare duodenal non-Hodgkin lymphoma in a 71-year-old woman, identified as natural killer (NK) cell lymphoma. Despite intensive chemotherapy, the patient had a poor prognosis, highlighting the aggressive nature of extranasal NK/T-cell lymphomas.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Non-Hodgkin lymphoma (NHL) encompasses a diverse group of lymphoid malignancies.
- Extranodal natural killer (NK)/T-cell lymphoma, nasal type, is a distinct entity often associated with specific demographic and geographic factors.
- Gastrointestinal involvement by NK/T-cell lymphoma is exceptionally rare.
Observation:
- A 71-year-old woman presented with duodenal non-Hodgkin lymphoma.
- Immunohistochemical analysis revealed lymphoma cells positive for CD2, cytoplasmic CD3, CD7, and CD56, with a negative T-cell receptor gene rearrangement.
- Morphological features, including high nuclear-to-cytoplasmic ratio and irregular nuclear outlines, supported an NK cell origin.
Findings:
- The duodenal lymphoma was characterized as a CD56-positive lymphoma, consistent with NK cell lineage.
- The patient received intensive chemotherapy but experienced a rapid decline, succumbing three weeks post-diagnosis.
- This case represents an extremely rare extranasal manifestation of NK/T-cell lymphoma.
Implications:
- Extranasal NK/T-cell lymphomas, particularly those in the gastrointestinal tract, are rare and associated with a poor prognosis.
- The heterogeneity of extranodal NK/T-cell lymphomas underscores the need for further research into their subclassification and treatment strategies.
- This case highlights the diagnostic challenges and aggressive clinical course of rare extranasal NK/T-cell lymphomas.